Inside Washington: Coverage and Consolidation ? Key Issues for Biotech Companies

January 15, 2003

Jill Wechsler

Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.

BioPharm International, BioPharm International-01-01-2003, Volume 16, Issue 1

by Jill Wechsler Manufacturers are concerned about congressional efforts to establish a Medicare pharmacy benefit and to regulate research while FDA shifts regulation of biologics and other drugs.